These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12613663)

  • 1. Protein misfolding and disease: the case of prion disorders.
    Hetz C; Soto C
    Cell Mol Life Sci; 2003 Jan; 60(1):133-43. PubMed ID: 12613663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond.
    Soto C; Saborio GP; Anderes L
    Trends Neurosci; 2002 Aug; 25(8):390-4. PubMed ID: 12127750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
    Singh J; Udgaonkar JB
    Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion protein diversity and disease in the transmissible spongiform encephalopathies.
    Priola SA
    Adv Protein Chem; 2001; 57():1-27. PubMed ID: 11447687
    [No Abstract]   [Full Text] [Related]  

  • 5. Folding and misfolding of the prion protein in the secretory pathway.
    Tatzelt J; Winklhofer KF
    Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein misfolding.
    Kupfer L; Hinrichs W; Groschup MH
    Curr Mol Med; 2009 Sep; 9(7):826-35. PubMed ID: 19860662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The state of the prion.
    Weissmann C
    Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Quick Method to Evaluate the Effect of the Amino Acid Sequence in the Misfolding Proneness of the Prion Protein.
    Fernández-Borges N; Eraña H; Elezgarai SR; Harrathi C; Venegas V; Castilla J
    Methods Mol Biol; 2017; 1658():205-216. PubMed ID: 28861792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion seeded conversion and amplification assays.
    Orrú CD; Caughey B
    Top Curr Chem; 2011; 305():121-33. PubMed ID: 21678135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion protein aggregation and fibrillogenesis in vitro.
    Stöhr J
    Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion proteins meet protein quality control.
    Dimcheff DE; Portis JL; Caughey B
    Trends Cell Biol; 2003 Jul; 13(7):337-40. PubMed ID: 12837603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomedicine. A view from the top--prion diseases from 10,000 feet.
    Priola SA; Chesebro B; Caughey B
    Science; 2003 May; 300(5621):917-9. PubMed ID: 12738843
    [No Abstract]   [Full Text] [Related]  

  • 14. Prion protein interconversions and the transmissible spongiform encephalopathies.
    Horiuchi M; Caughey B
    Structure; 1999 Oct; 7(10):R231-40. PubMed ID: 10545332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
    Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
    PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stressing out the ER: a role of the unfolded protein response in prion-related disorders.
    Hetz CA; Soto C
    Curr Mol Med; 2006 Feb; 6(1):37-43. PubMed ID: 16472111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chaperone-supervised conversion of prion protein to its protease-resistant form.
    DebBurman SK; Raymond GJ; Caughey B; Lindquist S
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13938-43. PubMed ID: 9391131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 mice.
    Määttänen P; Taschuk R; Ross L; Marciniuk K; Bertram L; Potter A; Cashman NR; Napper S
    Prion; 2013; 7(5):434-9. PubMed ID: 24105298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian prion proteins.
    Jackson GS; Clarke AR
    Curr Opin Struct Biol; 2000 Feb; 10(1):69-74. PubMed ID: 10679460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell culture models of transmissible spongiform encephalopathies.
    Béranger F; Mangé A; Solassol J; Lehmann S
    Biochem Biophys Res Commun; 2001 Nov; 289(2):311-6. PubMed ID: 11716473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.